Track PJSC Pharmsynthez's inventory ($49M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), LIFE.ME shows a inventory of $49M. That compares with $68M in the prior-year period — down 27.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, LIFE.ME's inventory is now $49M (was $68M) — a 27.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether PJSC Pharmsynthez is outperforming or lagging.
Tracking LIFE.ME's inventory over time shows whether PJSC Pharmsynthez is scaling, shrinking, or reshaping that part of the business. The current reading is $49M That compares with $68M in the prior-year period — down 27.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this inventory page, Stockcircle has PJSC Pharmsynthez's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $49M) with ownership activity and broader fundamentals.
PJSC Pharmsynthez's inventory is $49M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.